Financials in USD. Standardized financial statements.
A compact view of how ShockWave Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Revenue? | $730.23M | $489.73M | $237.15M | $67.79M | $42.93M | $12.26M | $1.72M |
| Revenue Growth? | +49.1% | +106.5% | +249.8% | +57.9% | +250.1% | +613.4% | 0.0% |
| Cost of Revenue? | $95.39M | $65.00M | $41.44M | $20.99M | $17.16M | $7.25M | $2.84M |
| Gross Profit? | $634.84M | $424.74M | $195.71M | $46.80M | $25.77M | $5.01M | -$1.12M |
| Gross Margin? | +86.9% | +86.7% | +82.5% | +69.0% | +60.0% | +40.9% | -65.0% |
| Operating Expenses? | $468.85M | $300.60M | $196.58M | $112.46M | $77.61M | $46.21M | $29.75M |
| Operating Income? | $165.99M | $124.13M | -$871,000 | -$65.66M | -$51.84M | -$41.20M | -$30.86M |
| EBITDA? | $190.83M | $127.57M | -$871,000 | -$63.15M | -$47.76M | -$39.91M | -$30.03M |
| Income Before Tax | $174.28M | $120.83M | -$8.84M | -$65.62M | -$51.05M | -$41.06M | -$30.59M |
| Income Tax Expense | $27.00M | -$95.17M | $301,000 | $80,000 | $62,000 | $38,000 | $26,000 |
| Net Income? | $147.28M | $216.00M | -$9.14M | -$65.70M | -$51.11M | -$41.10M | -$30.61M |
| EPS? | $4.01 | $6.02 | $-0.26 | $-1.99 | $-2.14 | $-1.53 | $-1.57 |
| Diluted EPS? | $3.85 | $5.70 | $-0.26 | $-1.99 | $-2.14 | $-1.53 | $-1.57 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality